Vivelle-Dot vs. Estradiol

See how Vivelle-Dot and Estradiol compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Vivelle-Dot is a twice-weekly estrogen patch, while Estradiol tablets are swallowed once or more times daily, but both deliver the same active hormone.

  • Both carry the same boxed warnings for blood clots, stroke, endometrial cancer, and dementia risk in women 65 and older.

  • Generic oral Estradiol costs far less than brand-name Vivelle-Dot, though the patch skips the liver on its way into the bloodstream.

Vivelle-Dot vs. Estradiol Drug Summary

Vivelle-Dot

Vivelle-Dot is a brand-name estrogen patch used to treat moderate to severe hot flashes and vaginal dryness from menopause, and to help prevent bone loss afterward. The patch releases estradiol continuously through the skin and is changed twice a week. Dosing starts low and is adjusted based on symptom relief.

Estradiol

Estradiol tablets contain the same estrogen hormone as Vivelle-Dot, taken by mouth to relieve menopausal hot flashes and vaginal dryness, treat low estrogen from ovarian failure, and prevent osteoporosis. Higher doses also palliate certain breast and prostate cancers. Tablets are taken once daily for most uses, or three times daily for cancer treatment.

Vivelle-Dot vs. Estradiol Side Effects

Vivelle-Dot

Most common
Nasopharyngitis (up to 19.6%)
Upper respiratory infection (up to 17%)
Sinusitis (up to 13.1%)
Sinus headache (up to 10.6%)

Estradiol

Most common
Nasopharyngitis (up to 19.6%)
Upper respiratory infection (up to 17%)
Sinusitis (up to 13.1%)
Sinus headache (up to 10.6%)

Vivelle-Dot vs. Estradiol Dosage

Vivelle-Dot

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.025 mg/day twice weekly At the start
Maximum dose 0.1 mg/day twice weekly If needed
Dose changes 4 increases As tolerated

Estradiol

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.5 mg once daily At the start
Maximum dose 10 mg three times daily If needed
Dose changes 4 increases As tolerated

Vivelle-Dot vs. Estradiol Indications

Vivelle-Dot

Vivelle-Dot is FDA-approved for moderate to severe hot flashes, vaginal dryness, and to help prevent bone thinning after menopause. It is also approved for low estrogen caused by ovarian failure, surgical removal of the ovaries, or hypogonadism. It is sometimes prescribed off-label as part of gender-affirming hormone therapy.

  • Moderate to severe hot flashes and night sweats

  • Vaginal dryness and irritation from menopause

  • Prevention of osteoporosis after menopause

  • Low estrogen from ovarian failure or hypogonadism

  • Off-label: gender-affirming hormone therapy

Estradiol

Oral Estradiol treats the same core menopause symptoms and low-estrogen conditions as Vivelle-Dot, plus uses the patch does not cover. At higher doses, it is FDA-approved to palliate metastatic breast cancer in select patients and advanced prostate cancer in men. It also carries off-label use in gender-affirming hormone therapy.

  • Moderate to severe hot flashes and night sweats

  • Vaginal dryness and irritation from menopause

  • Prevention of osteoporosis after menopause

  • Palliative therapy for certain breast and prostate cancers

  • Off-label: gender-affirming hormone therapy

Vivelle-Dot vs. Estradiol Pros and Cons

Vivelle-Dot

Vivelle-Dot's transdermal delivery bypasses first-pass liver metabolism, which may carry a lower clot risk than oral estrogen. As a brand-name patch, it can face insurance hurdles like prior authorization, and pharmacies can often substitute a generic patch instead.

Pros

  • Transdermal route may carry lower clot risk than pills

  • Changed only twice a week, no daily pill to remember

  • Five dose strengths allow precise titration

  • Stays on during showering, swimming, and exercise

Cons

  • Costs roughly $150 to $450 per month without insurance

  • Cannot be applied to the breasts; limited to abdomen or buttocks

  • Adhesive can cause skin irritation at the site

  • Not approved for cancer palliation, unlike oral estradiol

Estradiol

Oral Estradiol delivers the same hormone through the digestive system and liver, which may carry a slightly higher clot and stroke risk than transdermal options. Generic tablets are widely stocked, inexpensive, and rarely require prior authorization from insurers.

Pros

  • Generic tablets cost as little as $10 to $20 per month

  • Widely available with few insurance coverage barriers

  • Also approved for palliative breast and prostate cancer therapy

  • Familiar once-daily pill dosing for most patients

Cons

  • Oral route processed through the liver, may raise clot risk

  • Requires daily pills, or three times daily for cancer dosing

  • No fine dose adjustment between tablet strengths like patch offers

  • Not available as a patch, so no twice-weekly option

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.